The present epidemic of retinopathy of prematurity (ROP) is attributed to the increased survival ofvery premature infants.' The survival of very premature neonates has been significantly improved by the use of exogenous surfactant to treat respiratory distress syndrome (RDS).2 RDS is due to deficiency of surfactant which is a complex mixture of phospholipids and proteins, produced in the lungs, which reduces the surface tension and so prevents alveolar collapse. Very premature babies treated with surfactant for RDS have a marked improvement in morbidity as well as mortality.3
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The aetiology of ROP is uncertain. One important factor is gestational age which is inversely related to the incidence of ROP.47 If gestational age were the sole factor influencing the incidence of ROP then one would expect that the increased survival due to surfactant use would result in an increased incidence of ROP. On the other hand, if respiratory health and homeostasis are also significant determinants of ROP development, then the use of surfactant would be expected to reduce the gestational age-adjusted incidence of ROP. The effect of surfactant upon the overall incidence of ROP would then be determined by the balance of these two opposing effects.
More recently, exogenous surfactant has been used prophylactically in those neonates most at risk of developing RDS. During 1990 and 1991 a multicentre, randomised controlled trial (OSIRIS) compared neonates who received prophylactic surfactant within 2 hours of birth with a control group of neonates who received surfactant treatment only if they developed severe RDS ('rescue' treatment).8 This trial studied 2690 neonates and demonstrated that prophylactic surfactant markedly improved morbidity and mortality with a 16% decrease in death or chronic oxygen dependence at term. The markedly improved survival of premature neonates treated prophylactically with surfactant means that it would now be unethical to perform a prospective randomised trial of prophylactic surfactant. However, the neonates in the OSIRIS trial comprise a suitably randomised cohort, the survivors of which are available for examination.
This paper presents the results of examination of a regionally defined subset of the neonates in the OSIRIS trial, undertaken to determine the effect of prophylactic surfactant administration upon the incidence of ROP in very premature neonates.
Methods
The details of the controlled trial of prophylactic surfactant are published.8 In summary, all neonates born at less than 30 weeks' gestation were eligible for inclusion in the OSIRIS trial if the following criteria were met: (1) already intubated to receive respiratory support; (2) no congenital abnormality; (3) parental consent had been given; and (4) randomised before 2 Table 2 ). There was a non-significant improvement in morbidity in those receiving prophylactic surfactant: the mean time on the ventilator was reduced from 17-8 days to 15-1 days (p=031) and there were fewer neonates with pneumothoraces requiring drainage (5 9% compared with 9-8%, p=0Q41, Repka et al showed a decreased incidence of ROP after prophylactic surfactant compared with historical controlsl3 and no effect when contemporary controls were used.14 However, this latter study excluded the smallest babies who would be expected to have the highest incidence of ROP and therefore be the most likely to reveal any effect prophylactic surfactant may have had.
In our study, data from routine screening for acute ROP were not complete.15 This prevented proper statistical analysis but the data available are consistent with the results for cicatricial ROP. Thus, there was no significant difference between the two groups in the worst stage of acute ROP reached, with a trend for increased numbers without ROP in the prophylactic surfactant group. Bias Unknown stage 3 towards increased identification of acute ROP in the rescue group owing to a longer hospital stay seems unlikely as there was no significant difference in the number of screening examinations in the two groups. Bias due to easier examinations in less sick neonates is possible but would tend to identify more ROP in the prophylactic surfactant group and reduce any possible protective effect of prophylactic surfactant on development of severe ROP. This study has larger numbers than previous studies and is based on gestational age rather than birth weight, which has a closer correlation with the incidence of ROP.5-7 Nevertheless, the numbers with cicatricial ROP were not high enough to draw firm statistical conclusions. These results show a trend towards a reduction in gestational age-adjusted incidence of cicatricial ROP. If this trend is truly representative, then to have an 80% chance of demonstrating a significant difference (p=005) between the groups, it would have been necessary to examine 1400 children. The OSIRIS trial8 showed that prophylactic surfactant given to very premature neonates resulted in a 16% reduction in death or oxygen dependence at term (p=0-001) so such a study would be unethical. Thus, in the absence of further data, the following observations can be made which may offer some clues for future study.
The incidence of cicatricial ROP seems to be related to both gestational age and respiratory health of neonates. The survival of some neonates born at 23 weeks in the group receiving prophylactic surfactant was associated with a high incidence of cicatricial ROP (two of three survivors). As no babies born at 23 weeks survived in the rescue surfactant group, this is consistent with the hypothesis that ROP is related to gestational age and that factors improving survival increase the incidence of ROP.
The Prendiville and Schulenburg5 who showed a significant correlation between the development of severe acute ROP (stage 3 and 4) and three independent factors (acidosis, partial pressure of arterial oxygen (Pao2) >12 kPa, and pneumothorax) occurring before the onset of the demarcation line. In contrast, there was no difference in the exposure to any of their 34 risk factors between those neonates with mild (stage 1 and 2) and those with advanced (stage 3 and 4) acute ROP after the appearance of the demarcation line. 5 Administration of natural surfactant results in a rapid increase in Pao2 with marked hyperoxia occurring within 5 minutes. 3 The increase in Pao2 is less rapid after administration of synthetic surfactant16 such as Exosurf, but nevertheless there may be a period of instability with hyperoxia. All neonates in the rescue group who received surfactant had developed severe RDS. Therefore they would be expected to have had higher inspiratory oxygen requirements and ventilator pressures before surfactant treatment and greater fluctuations in Pao2 as a result of surfactant administration. There was also a higher incidence of pulmonary air leaks/pneumothoraces in the rescue surfactant group which may result in further fluctuations in Pao2.
Flynn et all7 also noted that Pao2 fluctuated over long periods in ventilated premature neonates despite transcutaneous oxygen monitoring and active control of inspired oxygen to avoid hyperoxia during study conditions. The time on the ventilator has been inversely related to the incidence of ROP.6 Premature neonates receiving prophylactic surfactant spent less time on the ventilator and this may be related to the effect of prophylactic surfactant on the incidence of cicatricial ROP.
In summary, although this study cannot draw any firm statistical conclusions it does suggest that improved survival does not necessarily result in an increased incidence of cicatricial ROP. Indeed, there may be further scope to improve the risk of ROP in very premature neonates by factors which affect respiratory health and physiological stability during the early neonatal period.
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